USE OF AMYGDALIN ANALOGUES FOR THE TREATMENT OF PSORIASIS
    2.
    发明公开
    USE OF AMYGDALIN ANALOGUES FOR THE TREATMENT OF PSORIASIS 有权
    VERWENDUNG VON AMYGDALIN-ANALOGA ZUR BEHANDLUNG VON PSORIASIS

    公开(公告)号:EP1847270A1

    公开(公告)日:2007-10-24

    申请号:EP05823007.9

    申请日:2005-11-25

    IPC分类号: A61K31/7028 A61P17/06

    CPC分类号: A61K31/7028

    摘要: The compounds of formula (I), wherein n is an integer from 0 to 4; R1 is a radical selected from the group consisting of H, CH 3 , CH 2 -CH 3 , C(CH 3 ) 3 , COOH, CONH 2 and C≡CH; R2, R3, R4 and R5 are radicals independently selected from the group consisting of H, F, Cl, Br, (C 1 -C 3 )-alkoxyl and (C 1 -C 4 )-alkyl; and R6 is a radical selected from the group consisting of H, F, Cl, Br, (C 1 -C 3 )-alkoxyl, (C 1 -C 4 )-alkyl, R7, CH=CH-R7 and O-CH 2 -R7; wherein R7 is phenyl or phenyl mono- or independently di-substituted with F, Cl, Br, (C 1 -C 3 )-alkoxyl or (C 1 -C 4 )-alkyl, exhibit a similar chemotactic index to that of amygdalin (natural product whose chemotaxis profile is similar to that of peptide T) and, consequently, are useful for treating inflammatory and/or allergic dermatophathies, such as psoriasis, and are especially much less toxic than amygdalin.

    摘要翻译: 式(I)的化合物,其中n为0至4的整数; R1是选自H,CH 3,CH 2 -CH 3,C(CH 3)3,COOH,CONH 2和C≡CH的基团; R 2,R 3,R 4和R 5是独立地选自H,F,Cl,Br,(C 1 -C 3) - 烷氧基和(C 1 -C 4) - 烷基的基团; 并且R 6是选自H,F,Cl,Br,(C 1 -C 3) - 烷氧基,(C 1 -C 4) - 烷基,R 7,CH = CH-R 7和O-CH 2 -R7; 其中R 7是苯基或被F,Cl,Br,(C 1 -C 3) - 烷氧基或(C 1 -C 4) - 烷基单取代或独立地二取代的苯基表现出与杏仁体相似的趋化指数( 天然产物,其趋化性状与肽T相似),因此可用于治疗炎症和/或过敏性皮肤病,如牛皮癣,并且特别是比杏仁苷毒性低得多。